Atai Life Sciences EBITDA Margin 2020-2024 | ATAI

Current and historical EBITDA (Earnings Before Interest, Taxes, Depreciation and Amortization) margin for Atai Life Sciences (ATAI) over the last 10 years. The current EBITDA margin for Atai Life Sciences as of September 30, 2024 is .
Atai Life Sciences EBITDA Margin Historical Data
Date TTM Revenue TTM EBITDA EBITDA Margin
2024-09-30 $0.00B $-0.11B inf%
2024-06-30 $0.00B $-0.11B inf%
2023-12-31 $0.00B $-0.13B inf%
2023-09-30 $0.00B $-0.13B inf%
2023-06-30 $0.00B $-0.14B inf%
2023-03-31 $0.00B $-0.14B inf%
2022-09-30 $0.00B $-0.15B inf%
2022-06-30 $0.00B $-0.15B inf%
2021-12-31 $0.02B $-0.14B -675.00%
Sector Industry Market Cap Revenue
Medical Medical - Outpatient & Home Care $0.356B $0.000B
atai Life Sciences B.V. is a clinical-stage biopharmaceutical company aiming to transform the treatment of mental health disorders. atai Life Sciences B.V. is based in BERLIN.
Stock Name Country Market Cap PE Ratio
Fresenius SE (FSNUY) Germany $21.312B 0.00
Quest Diagnostics (DGX) United States $18.153B 18.23
DaVita (DVA) United States $14.110B 18.25
Encompass Health (EHC) United States $9.934B 22.26
Chemed (CHE) United States $8.335B 25.62
Elanco Animal Health (ELAN) United States $5.917B 14.08
Option Care Health (OPCH) United States $5.245B 24.85
RadNet (RDNT) United States $4.764B 105.51
LifeStance Health (LFST) United States $3.053B 0.00
Amedisys (AMED) United States $3.017B 21.47
Addus HomeCare (ADUS) United States $2.171B 25.48
Astrana Health (ASTH) United States $2.001B 27.37
U.S Physical Therapy (USPH) United States $1.324B 34.81
Aveanna Healthcare Holdings (AVAH) United States $0.935B 0.00
Pennant (PNTG) United States $0.935B 37.81
Bioqual (BIOQ) United States $0.054B 0.00
Daxor (DXR) United States $0.038B 0.00
Ontrak (OTRK) United States $0.007B 0.00
MEDIROM Healthcare Technologies (MRM) Japan $0.005B 0.00
IMAC Holdings (BACK) United States $0.001B 0.00
Psychemedics (PMD) United States $0.000B 0.00